John F. Hamilton - 27 Jun 2024 Form 4 Insider Report for Aridis Pharmaceuticals, Inc.

Role
Director
Signature
/s/ John Hamilton
Issuer symbol
N/A
Transactions as of
27 Jun 2024
Net transactions value
$0
Form type
4
Filing time
28 Jun 2024, 20:36:10 UTC
Previous filing
19 Sep 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARDS Stock options Award $0 +200,000 +290% $0.000000 269,040 27 Jun 2024 Common Stock 200,000 $0.0630 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.